- Short-term effect of rosuvastatin versus atorvastatin on the corrected QT interval: a target trial emulation
European Journal of Clinical Pharmacology · 2026
- Clopidogrel Monotherapy in Patients With Chronic Coronary Syndrome Following Coronary Artery Bypass Grafting: A Nationwide Cohort Study
Korean Circulation Journal · 2026
- Atorvastatin Attenuates Human Cardiac Fibroblast Activation, with Associated Changes in GATA4/MEF2C and Selected Fibrosis-Related microRNAs
International Journal of Molecular Sciences · 2026
- ABSTRACT NUMBER: ESOC2026A1096 MECHANISMS OF RECURRENT ISCHEMIC STROKE AMONG PATIENTS WITH CRYPTOGENIC STROKE AND ATRIAL CARDIOPATHY: A SECONDARY ANALYSIS OF THE ARCADIA CLINICAL TRIAL
European Stroke Journal · 2026
- ABSTRACT NUMBER: ESOC2026A1384 QUANTITATIVE POINT-OF-CARE TESTING IN PATIENTS TREATED WITH APIXABAN
European Stroke Journal · 2026
- ABSTRACT NUMBER: ESOC2026A690 REAL-WORLD APIXABAN CONCENTRATIONS IN END-STAGE RENAL DISEASE AND HEMODIALYSIS
European Stroke Journal · 2026
- ABSTRACT NUMBER: ESOC2026YS208 CURRENT STATUS AND PROSPECTS OF RESEARCH ON THE MECHANISMS OF CLOPIDOGREL RESISTANCE
European Stroke Journal · 2026
- ABSTRACT NUMBER: ESOC2026A1595 COMBINED LIPID-LOWERING THERAPY WITH ATORVASTATIN AND EZETIMIBE IN PATIENTS WITH ISHEMIC STROKE AND DYSLIPIDEMIA: A RETROSPECTVE ANALYSIS
European Stroke Journal · 2026
- ABSTRACT NUMBER: ESOC2026OT190 COMBINATION ANTITHROMBOTIC TREATMENT FOR PREVENTION OF RECURRENT ISCHEMIC STROKE IN INTRACRANIAL ATHEROSCLEROTIC DISEASE. CATIS-ICAS
European Stroke Journal · 2026
- B64-09 Unexpected Pulmonary Embolism During Continuous Heparin Infusion in a Patient on Chronic Direct Oral Anticoagulation Therapy
American Journal of Respiratory and Critical Care Medicine · 2026
- B64-19 Hidden in Plain Sight: An Incidental Right Ventricular Thrombus Without Pulmonary Embolism
American Journal of Respiratory and Critical Care Medicine · 2026
- C52-03 Hemopericardium on Apixaban Resolved Post-CPR: An Unusual Case of Pericardial Rupture
American Journal of Respiratory and Critical Care Medicine · 2026
- B64-48 Massive Pulmonary Embolism With Refractory Right Ventricular (RV) Failure Despite Therapeutic Apixaban: The Institution’s First RV Impella Case
American Journal of Respiratory and Critical Care Medicine · 2026
- A37-13 Clinical and Behavioral Predictors of Patient-Reported Outcomes After Off-Pump CABG: A Cross-Sectional Study
American Journal of Respiratory and Critical Care Medicine · 2026
- A49-30 Silent Collapse: Think Outside the Box — Adult-onset Waterhouse-Friderichsen Syndrome
American Journal of Respiratory and Critical Care Medicine · 2026
- B64-40 Recurrent Thrombosis and Cteph Despite Doac Adherence: When Anticoagulation Fails
American Journal of Respiratory and Critical Care Medicine · 2026
- Oral Anticoagulants and Risk of Bleeding and Death in Cancer-Associated Venous Thromboembolism
JACC Advances · 2026
- Pharmacogenetic variants in pharmacokinetic and pharmacodynamic pathways and clinical factors associated with bleeding risk in Thai patients receiving rivaroxaban: a case–control study
Therapeutic Advances in Drug Safety · 2026
- Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impact
European Heart Journal · 2026
- IMPACT OF NEBIVOLOL PRESCRIPTION AT DISCHARGE ON LONG-TERM OUTCOMES IN STEMI PATIENTS WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION TREATED WITH DRUG-ELUTING STENTS
Journal of Hypertension · 2026
- CAROTID PLAQUES TREATED WITH BEMBEDOIC ACID: A 7% OF REDUCTION IN 6 MONTHS
European Heart Journal Supplements · 2026
- ATORVASTATIN/BEZAFIBRATE AND INTENSIVE PHYSICAL EXERCISE–INDUCED RHABDOMYOLYSIS IN A HYPERLIPIDEMIC PATIENT IN SECONDARY PREVENTION
European Heart Journal Supplements · 2026
- INCLISIRAN IN TWO VERY–HIGH CV RISK PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE
European Heart Journal Supplements · 2026
- Outcomes of extended reduced‐dose apixaban versus full‐dose apixaban in cancer‐associated venous thromboembolism
British Journal of Haematology · 2026
- Compliance with the Veterans Health Administration’s Pharmacy Benefit Management guidance for duration of clopidogrel following peripheral vascular interventions: a retrospective cohort study
Journal of Managed Care & Specialty Pharmacy · 2026
- A prospective series of acute rivaroxaban overdose, coagulopathy and bleeding complications (ATOM 11)
British Journal of Clinical Pharmacology · 2026
- Rivaroxaban safety and adherence in patients with nonvalvular atrial fibrillation: prospective, observational, cohort, postmarketing study
Journal of Cardiovascular Pharmacology · 2026
- Hypertension With High-Risk Features in Cryptogenic Stroke
JAMA Neurology · 2026
- Prevalence of Potentially Inappropriate Apixaban Prescribing Within a Single‐Centre Tertiary Hospital
Australasian Journal on Ageing · 2026
- Apixaban Overdose with Massive Bleeding and Anti-Xa Levels
Journal of Medical Toxicology · 2026
- Management of patients with protein s deficiency: focus on clinical course and direct oral anticoagulants
Thrombosis Journal · 2026
- TFPIα inhibition by Andexanet alfa is partially restored by protein S and factor V-short
Blood Advances · 2026
- Abstract 378: PGRMC1 induced lipid metabolic reprogramming leads to sorafenib resistance in hepatocellular carcinoma.
Cancer Research · 2026
- A-123 | PRACTICE SHIFT AND RISING USE OF APIXABAN FOR ATRIAL FIBRILLATION AND ATRIAL FLUTTER IN END-STAGE RENAL DISEASE: INSIGHTS FROM A 5-YEAR EPIC COSMOS ANALYSIS
Journal of the Society for Cardiovascular Angiography & Interventions · 2026
- Triple Therapy With Rivaroxaban in Patients With Acute Myocardial Infarction and Prior Atrial Fibrillation
Pacing and Clinical Electrophysiology · 2026
- Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies
Journal of the American College of Cardiology · 2026
- Extended Low-Dose Apixaban and Superficial Vein Thrombosis
JAMA Cardiology · 2026
- Cardioprotection with intravenous statin administration during myocardial infarction vs. oral preloading: a preclinical study
European Heart Journal · 2026
- Apixaban Pharmacotherapy Management: A Current and Updated Review
Current Drug Therapy · 2026
- Safety and Tolerability of Edoxaban in Filipino Patients With Non-valvular Atrial Fibrillation: A Pilot Post-marketing Surveillance Study
Cureus · 2026
- Nebivolol Inhibits Hepatocellular Carcinoma via RHOQ and Enhances the Efficacy of Lenvatinib
International Journal of Biological Sciences · 2026
- Direct Oral Anticoagulants and Incidence of Dementia in Patients With Nonvalvular Atrial Fibrillation
Neurology Open Access · 2026
- Atorvastatin and left ventricular strain during anthracycline-based chemotherapy
International Journal of Cardiology · 2026
- Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial Substudy
Journal of the American Heart Association · 2026
- Real-world use of rivaroxaban for primary thromboprophylaxis and cardiac thrombosis treatment in congenital and acquired heart disease: a prospective cohort study
Scientific Reports · 2026
- Response to: Comment on ‘comparative effectiveness of clopidogrel <i>vs</i> . potent P2Y12 inhibitors in CYP2C19 normal metabolizers following percutaneous coronary intervention: A real‐world cohort study’
British Journal of Clinical Pharmacology · 2026
- The impact of body composition variability on coagulation monitoring in patients on direct oral factor Xa inhibitors for treatment of venous thromboembolism
Frontiers in Cardiovascular Medicine · 2026
- Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
2026
- Effects of evolocumab combined with statin therapy on blood lipids, inflammatory factors, and endothelial function in patients with coronary heart disease
BMC Cardiovascular Disorders · 2026
- Safety and efficacy of rivaroxaban vs. vitamin K antagonists in patients with atrial fibrillation: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
European journal of medical research · 2026